ABCC11 expression (together with ABCB1) is responsible for resistant phenotype of breast cancer cell lines resistant to eribulin and inhibition of ABCC11 can partially restore the cross-resistance to 5-fluorouracil [33]. The gene discussed is ABCB1; the disease is breast cancer.